Evidence map›Paper›PMID 26396712›Full record

ArticleJundishapur journal of microbiology2015

The Prevalence of IS Aba 1 and IS Aba 4 in Acinetobacter baumannii Species of Different International Clone Lineages Among Patients With Burning in Tehran, Iran.

Abbas Bahador, Reza Raoo An, Zahra Farshadzadeh, Leyli Beitollahi, Azad Khaledi, Sara Rahimi, Masoumeh Mokhtaran, Ali Mehrabi Tavana, Davood Esmaeili

Open access · hybridAbstract read
In one paragraph

Article in Jundishapur journal of microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Prevalence of Integrons and Antibiotic Resistance Pattern inEthiopian journal of health sciences · 2019
    Pooled it
  2. Molecular Characterization of Carbapenem-ResistantInfection and drug resistance · 2022
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Extensive colonization with carbapenemase-producing microorganisms in Romanian burn patients: infectious consequences from the Colectiv fire disaster.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2018
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Abbas BahadorDepartment of Microbiology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, IR Iran.
Reza Raoo AnDepartment of Genetic, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran.
Zahra FarshadzadehDepartment of Microbiology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, IR Iran.
Leyli BeitollahiDepartment of Microbiology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, IR Iran.
Azad KhalediDepartment of Microbiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran.
Sara RahimiDepartment of Microbiology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, IR Iran.
Masoumeh MokhtaranDepartment of Microbiology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, IR Iran.
Ali Mehrabi TavanaHealth Management Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran.
Davood EsmaeiliApplied Microbiology Research Center, Department of Microbiology, Baqiyatallah University of Medical Sciences, Tehran, IR Iran.
Tehran University of Medical Sciences · IRBaqiyatallah University of Medical Sciences · IRMashhad University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMultidrug resistant strains of Acinetobacter baumannii (MDR-AB) have emerged as alarming nosocomial pathogens among patients with burning.

objectivesThe current study aimed to determine the susceptibility of A. baumannii species, carbapenems resistance patterns, and their association with IS Aba 1 and IS Aba 4 elements upstream of the bla OXA-like genes, and the distribution of international clone (IC) of A. baumannii isolates among patients with burning in Tehran, Iran. MATERIALS AND

methodsIn the current study, 62 A. baumannii species isolates from patients with burning in Tehran, Iran, in 2012 were evaluated for the antimicrobial susceptibility, genetic relationships, ICs, carbapenemase encoding genes, and insertion elements IS Aba upstream of bla OXA-like genes.

resultsThe highest rates of susceptibility were observed with colistin (88.7%) and tigecycline (82.2%). The extensively drug-resistance and pan drug-resistance were observed in 37.1% and 8.1% of the isolates, respectively. About 98.3% of 17 genotypes categorized into three distinct clusters. Thirty-six of the 62 isolates (58%) belonged to the IC II lineage. The most prevalent acquired OXA-type carbapenemase was bla OXA-23-like (62.9%). IS Aba 1 and IS Aba 4 were detected upstream of bla OXA-23-like genes in 45.1% and 12.9% of isolates, respectively. In 32.2% of all isolates, IS Aba 1 laid upstream of bla OXA-51-like genes. The PCR results were negative for carbapenemase genes of Ambler class A and B, except bla VIM-2 . (1.6%).

conclusionsIt was the first study that attempted to detect the insertion elements IS Aba and IC lineages in MDR-AB species isolated from patients with burning in Iran.

Indexed as

Acinetobacter baumanniibeta-LactamasesCarbapenemaseDrug ResistanceIS elementsMolecular Epidemiology

Identifiers

PMID26396712
PMCPMC4575776
OpenAlexW2336024670

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.